National burden of preventable adverse drug events associated with inpatient injectable medications: Healthcare and medical professional liability costs

American Health and Drug Benefits

Volumn 5, Issue 7, 2012, Pages

  Lahue, Betsy J ^a   Pyenson, Bruce S ^b   Iwasaki, Kosuke ^b   Blumen, Helen E ^b   Forray, Susan ^b   Rothschild, Jeffrey M ^c  

^a BD Technologies   (United States)

^b MILLIMAN INC   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANXIOLYTIC AGENT; FIBRINOLYTIC AGENT; INSULIN; NARCOTIC ANALGESIC AGENT; SEDATIVE AGENT;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIAGNOSIS RELATED GROUP; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG SAFETY; HEALTH CARE COST; HIGH RISK PATIENT; HOSPITAL CARE; HOSPITAL COST; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INJECTION; INVESTMENT; MAJOR CLINICAL STUDY; MEDICAL ERROR; MEDICAL LIABILITY; PREVENTION STUDY; RISK ASSESSMENT; UNITED STATES; UNSPECIFIED SIDE EFFECT;

EID: 84871600424     PISSN: 19422962     EISSN: 19422970     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. New England Health Institute. Preventing medication errors: a $21 billion opportunity. www.nehi.net/bendthecurve/sup/documents/Medication_Errors_%20Brief.pdf. Accessed September 17, 2012.
2. Committee on Quality of Health Care in America, Institute of Medicine. Errors in health care: a leading cause of death and injury. In: Kohn LT, Corrigan JM, Donaldson MS, eds. To Err Is Human: Building a Safer Health System. Washington, DC: National Academies Press; 2000.
3. Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA. 1995;274:35-43.
4. Committee on Identifying and Preventing Medication Errors, Institute of Medicine. Medication errors: incidence and cost. In: Preventing Medication Errors: Quality Chasm Series. Washington, DC: National Academies Press; 2007.
5. Levinson DR. Adverse events in hospitals: national incidence among Medicare beneficiaries. US Dept of Health and Human Services, Office of Inspector General. November 2010. OEI-06-09-00090. https://oig.hhs.gov/oei/reports/oei-06-09-00090.pdf. Accessed November 15, 2012.
6. Poon EG, Keohane CA, Yoon CS, et al. Effect of bar-code technology on the safety of medication administration. N Engl J Med. 2010;362:1698-1707.
7. Barker KN, Flynn EA, Pepper GA, et al. Medication errors observed in 36 health care facilities. Arch Intern Med. 2002;162:1897-1903.
8. Adapa RM, Mani V, Murray LJ, et al. Errors during the preparation of drug infusions: a randomized controlled trial. Br J Anaesth. 2012;109:729-734.
9. Kale A, Keohane CA, Maviglia S, et al. Adverse drug events caused by serious medication administration errors. BMJ Qual Saf. 2012;21:933-938.
10. Osmon S, Harris CB, Dunagan WC, et al. Reporting of medical errors: an intensive care unit experience. Crit Care Med. 2004;32:727-733.
11. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA. 1997;277:307-311.
12. Classen DC, Pestotnik SL, Evans RS, Burke JP. Computerized surveillance of adverse drug events in hospital patients. JAMA. 1991;266:2847-2851.
13. Rothschild JM, Federico FA, Gandhi TK, et al. Analysis of medication-related malpractice claims: causes, preventability, and costs. Arch Intern Med. 2002;162: 2414-2420.
14. Sanborn MD, Moody ML, Harder KA, et al. Second Consensus Development Conference on the Safety of Intravenous Drug Delivery Systems-2008. Am J Health Syst Pharm. 2009;66:185-192.
15. Medical Liability Monitor annual rate survey. Medical Liability Monitor. 2011; 36:7-43.
16. Van Den Bos J, Rustagi K, Gray T, et al. The $17.1 billion problem: the annual cost of measurable medical errors. Health Aff (Millwood). 2011;30:596-603.
17. Bates DW, Teich JM, Lee J, et al. The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc. 1999;6:313-321.
18. Chapuis C, Roustit M, Bal G, et al. Automated drug dispensing system reduces medication errors in an intensive care setting. Crit Care Med. 2010;38:2275-2281.
19. Beyea SC, Hicks RW, Becker SC. Medication errors in the OR-a secondary analysis of Medmarx. AORN J. 2003;77:122,125-129,132-134.
20. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995;274:29-34.
21. Rothschild JM, Keohane CA, Cook EF, et al. A controlled trial of smart infusion pumps to improve medication safety in critically ill patients. Crit Care Med. 2005;33: 533-540.
22. SEA Medical Systems. Technology. www.seamedical.com/?pg=products. Accessed September 17, 2012.
23. Meddings JA, Reichert H, Rogers MA, et al. Effect of nonpayment for hospital-acquired, catheter-associated urinary tract infection: a statewide analysis. Ann Intern Med. 2012;157:305-312.
24. Levinson DR. Hospital incident reporting systems do not capture most patient harm. US Dept of Health and Human Services, Office of Inspector General. January 2012. Report No OEI-06-09-00091. http://psnet.ahrq.gov/resource.aspx? resourceID=23842. Accessed November 24, 2012.
25. Cure L, Zayas-Castro J, Fabri P. Clustering-based methodology for analyzing near-miss reports and identifying risks in healthcare delivery. J Biomed Inform. 2011;44: 738-748.